Marinus Pharmaceuticals Inc (MRNS)
1.51
+0.06
(+4.14%)
USD |
NASDAQ |
May 03, 16:00
1.515
0.00 (0.00%)
After-Hours: 20:00
Marinus Pharmaceuticals Accounts Receivable (Quarterly): 3.799M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.799M |
September 30, 2023 | 4.281M |
June 30, 2023 | 5.234M |
March 31, 2023 | 11.69M |
December 31, 2022 | 6.348M |
September 30, 2022 | 3.398M |
June 30, 2022 | 3.00M |
March 31, 2022 | 2.489M |
December 31, 2021 | 2.629M |
Date | Value |
---|---|
September 30, 2021 | 2.473M |
June 30, 2021 | 4.201M |
March 31, 2021 | 2.65M |
December 31, 2020 | 1.646M |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2019
11.69M
Maximum
Mar 2023
3.846M
Average
3.199M
Median
Accounts Receivable (Quarterly) Benchmarks
Ligand Pharmaceuticals Inc | 32.92M |
Soligenix Inc | 0.00 |
Actinium Pharmaceuticals Inc | -- |
Macrogenics Inc | 10.37M |
ADMA Biologics Inc | 27.42M |